Updates

Get Alerts
With a free MyAccess profile, you can sign up to receive an email alert when new content is published on this site.
6/21/2017 12:50:22 PM | Goodman & Gilman's The Pharma. Basis of Therapeutics Updates General Update The Goodman & Gilman Year in Review: 2016 New and Noteworthy FDA Approvals Nelda Murri, PharmD, MBA
6/19/2017 7:27:18 PM | Goodman & Gilman's The Pharma. Basis of Therapeutics Updates General Update The Goodman & Gilman Year in Review: 2016 New and Noteworthy FDA Approvals Nelda Murri, PharmD, MBA
6/19/2017 7:27:18 PM | Goodman & Gilman's The Pharma. Basis of Therapeutics Updates General Update The Goodman & Gilman Year in Review: 2016 New and Noteworthy FDA Approvals Nelda Murri, PharmD, MBA
3/15/2016 2:22:40 PM | Goodman & Gilman's The Pharma. Basis of Therapeutics Updates General Update Year in Review: 2014 New and Noteworthy FDA Approvals (ABSTRACT) Nelda Murri, PharmD, MBA
12/2/2015 6:00:53 PM | Goodman & Gilman's The Pharma. Basis of Therapeutics Updates General Update Update 62-1 Idelalisib: A First-in-Class Specific Inhibitor of PI3Kδ for the Treatment of B-cell lymphomas (ABSTRACT) Randa Hilal-Dandan, PhD
2/25/2015 2:22:36 PM | Goodman & Gilman's The Pharma. Basis of Therapeutics Updates General Update Programmed Cell Death-1 (PD-1) Pathway Checkpoint Inhibition: Immuno-oncology for Advanced Melanoma David Woessner, PhD, MS
1/6/2015 4:50:25 PM | Goodman & Gilman's The Pharma. Basis of Therapeutics Updates General Update Perspective on Transgenic Animal Drug Production Nelda Murri, PharmD, MBA